Balloon guide catheter versus different sizes of non-balloon guide catheter; a MR CLEAN Registry analysis.
Knapen, R. R. M. M.; CONTRAST Consortium, ; Goldhoorn, R.-J.; Hofmeijer, J.; Lycklama A Nijeholt, G. J.; van den Berg, R.; van den Wijngaard, I. R.; van Oostenbrugge, R. J.; van Zwam, W. H.; van der Leij, C.
Show abstract
IntroductionBalloon guide catheters (BGC) are used to prevent distal emboli during endovascular treatment (EVT) for acute ischemic stroke. Although literature reports benefit of BGC, these are not universally used and randomized head-to-head comparisons are lacking. This study compared functional, safety, and technical outcomes between patients treated with different sizes non-BGC and with BGC during EVT in a nationwide prospective multicenter registry. MethodsPatients from the MR CLEAN Registry (2014-2018), who underwent EVT with a 5-7French (Fr) non-BGC, a 8-9Fr non-BGC, or a 8-9Fr BGC were included. Primary outcome was the modified Rankin Scale (mRS) score at 90 days, secondary outcomes included procedure time and first-attempt successful reperfusion (eTICI [≥] 2C). Treatment-effect modification and subgroups were analyzed according to first-line thrombectomy technique: stent retriever (SR) or direct aspiration (ASP). ResultsIn total 2808 patients were included, and 1671 (60%) were treated with 8-9Fr BGC. Overall, no significant differences in clinical outcome were seen between non-BGC and BGC groups. The 8-9Fr non-BGC was associated with lower first-attempt successful revascularization rates compared to BGC (aOR:0.76, 95%CI:0.59-0.998), the 5-7 Fr non-BCG was not. Regression analysis showed a significant interaction between BGC use and device type. In the subgroup with SR as first-line technique, 90 day mRS scores were significantly higher in the 8-9Fr non-BGC group compared with BCG (acOR:0.77; 95%CI:0.59-0.996), but not in the 5-7Fr non-BCG. Direct aspiration combined with 5-7Fr non-BGC resulted in higher first-attempt rates compared to BGC (aOR:1.75; 95%CI:1.16-2.63). ConclusionThis large prospective multicenter registry showed no differences in clinical outcome between patients treated with 5-7Fr non-BGC, 8-9Fr non-BGC, and 8-9Fr BGC. Subgroup analyses, however, suggest that BCG outperforms the non-BGC when SR is used as first-line technique.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Large Core Thrombectomy: Feasibility Of Simplified Protocol In Resource-Limited Settings 97%
- Long term stability of patients undergoing endovascular parent artery occlusion of their intracranial artery 97%
- Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial 97%
Similar papers in this journal
- Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions 97%
- Prospective Observational Cohort Study Of Tenecteplase Versus Alteplase In Routine Clinical Practice 97%
- Normobaric Hyperoxia Combined with Endovascular Treatment Based on Temporal Gradient: A dose-escalation study 96%
Similar papers in this journal
- Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - a propensity score-matched analysis 94%
- Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke 94%
- Leveraging Machine Learning for Enhanced and Interpretable Risk Prediction of Venous Thromboembolism in Acute Ischemic Stroke Care 94%
Similar papers in this journal
- CT-Perfusion absolute Ghost Infarct Core is a rare phenomenon associated with poor collateral status in acute ischemic stroke patients 95%
- Five-year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome. A meta-analysis. 92%
- Atrial Fibrillation Catheter Ablation among Cancer Patients: Utilization Trends and In-Hospital Outcomes 92%
Similar papers in this journal
- Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia. The Randomized RAIN-FLOW Study 96%
- Predictors of survival in patients with ischemic stroke and active cancer: A prospective, multicenter, observational study 96%
- Tenecteplase 0.4 mg/kg in moderate and severe acute ischemic stroke: A pooled analysis of NOR-TEST & NOR-TEST 2A 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.